Olema Pharmaceuticals, Inc. (OLMA) Balance Sheet
As of 2026-06-30 (10-Q), Olema Pharmaceuticals, Inc. (OLMA) reported total assets of $486.6M, total liabilities of $56.0M and shareholders' equity of $430.6M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $48.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OLMAOlema Pharmaceuticals, Inc.Follow OLMA — free
—
Price chart with a free account
- Market cap
- 560.9M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 13.8 | 23.7 | 68.5 | 139.5 | 48.3 | 48.6 | |
| Short-term investments | 273.4 | 180.7 | 193.3 | 294.6 | 457.1 | 412.5 | |
| Current assets | 290.7 | 208.9 | 266.5 | 438.5 | 515.5 | 469.9 | |
| Total assets | 295.9 | 215.6 | 276.9 | 451.0 | 533.4 | 486.6 | |
| Current liabilities | 9.0 | 16.5 | 21.6 | 41.8 | 51.8 | 53.0 | |
| Total liabilities | 11.4 | 18.1 | 23.1 | 42.0 | 54.9 | 56.0 | |
| Shareholders' equity | 284.6 | 197.5 | 253.9 | 409.0 | 478.6 | 430.6 |
USD millions · SEC XBRL
Olema Pharmaceuticals, Inc. — questions
- How much cash does Olema Pharmaceuticals, Inc. have?
- $48.6M in cash and cash equivalents as of 2026-06-30.
- What are Olema Pharmaceuticals, Inc.'s total assets?
- $486.6M as of 2026-06-30.
- What is Olema Pharmaceuticals, Inc.'s shareholders' equity?
- $430.6M as of 2026-06-30.
Every figure on this page comes from Olema Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.